NATULAN

This brand name is authorized in Estonia, France, Malta, Netherlands, Romania, Spain.

Active ingredients

The drug NATULAN contains one active pharmaceutical ingredient (API):

1
UNII XH0NPH5ZX8 - PROCARBAZINE HYDROCHLORIDE
 

Procarbazine, a methylhydrazine derivative, is a cytostatic agent with weak MAO inhibitor properties. Its exact mode of action on tumour cells is unknown.
 
Read more about Ibenzmethyzine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
L01XB01 Procarbazine L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XB Methylhydrazines
Discover more medicines within L01XB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1106637
ES Centro de información online de medicamentos de la AEMPS 42248
FR Base de données publique des médicaments 69245055
MT Medicines Authority AA153/02001, AA729/26301
NL Z-Index G-Standaard, PRK 1899
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W59766002

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈